Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Abstract:
Induced pluripotent stem (iPS) cells have been generated frommouse and human fibroblasts by the retroviral transduction offour transcription factors. However, the cell origins and molecularmechanisms of iPS cell induction remain elusive. This reportdescribes the generation of iPS cells from adult mouse hepatocytesand gastric epithelial cells. These iPS cell clones appear tobe equivalent to embryonic stem cells in gene expression andare competent to generate germline chimeras. Genetic lineagetracings show that liver-derived iPS cells are derived fromalbumin-expressing cells. No common retroviral integration sitesare found among multiple clones. These data suggest that iPScells are generated by direct reprogramming of lineage-committedsomatic cells and that retroviral integration into specificsites is not required.
1 Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan. 2 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan. 3 Core Research in Embryonic Science and Technology (CREST), Japan Science and Technology Agency, Kawaguchi 332-0012, Japan. 4 Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA. 5 Center for Induced Pluripotent Stem (iPS) Cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.
* To whom correspondence should be addressed. E-mail: yamanaka{at}frontier.kyoto-u.ac.jp
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Annalisa M. VanHook (5 August 2008) Sci. Signal.1 (31), ec280.
[DOI: 10.1126/scisignal.131ec280] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells.
I. Grabundzija, J. Wang, A. Sebe, Z. Erdei, R. Kajdi, A. Devaraj, D. Steinemann, K. Szuhai, U. Stein, T. Cantz, et al. (2013)
Nucleic Acids Res.
41, 1829-1847
|Abstract »|Full Text »|PDF »
Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells.
H. Okano, M. Nakamura, K. Yoshida, Y. Okada, O. Tsuji, S. Nori, E. Ikeda, S. Yamanaka, and K. Miura (2013)
Circ. Res.
112, 523-533
|Abstract »|Full Text »|PDF »
Expression Analysis of iPS Cell - Inductive Genes in Esophageal Squamous Cell Carcinoma by Tissue Microarray.
Y. SHIMADA, T. OKUMURA, S. SEKINE, M. MORIYAMA, S. SAWADA, K. MATSUI, I. YOSHIOKA, S. HOJO, T. YOSHIDA, T. NAGATA, et al. (2012)
Anticancer Res
32, 5507-5514
|Abstract »|Full Text »|PDF »
Endothelial Cardiac Cell Therapy: Large-Animal Studies and the Elephant in the Room.
W.-Y. Chen and R. T. Lee (2012)
Circ. Res.
111, 824-826
|Full Text »|PDF »
Microfluidic Single-Cell Analysis Shows That Porcine Induced Pluripotent Stem Cell-Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation.
M. Gu, P. K. Nguyen, A. S. Lee, D. Xu, S. Hu, J. R. Plews, L. Han, B. C. Huber, W. H. Lee, Y. Gong, et al. (2012)
Circ. Res.
111, 882-893
|Abstract »|Full Text »|PDF »
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.
J. F. Islas, Y. Liu, K.-C. Weng, M. J. Robertson, S. Zhang, A. Prejusa, J. Harger, D. Tikhomirova, M. Chopra, D. Iyer, et al. (2012)
PNAS
109, 13016-13021
|Abstract »|Full Text »|PDF »
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
K. Streckfuss-Bomeke, F. Wolf, A. Azizian, M. Stauske, M. Tiburcy, S. Wagner, D. Hubscher, R. Dressel, S. Chen, J. Jende, et al. (2012)
Eur. Heart J.
|Abstract »|Full Text »|PDF »
Cellular reprogramming - lowering gravity on Waddington's epigenetic landscape.
Generation of Retinal Pigment Epithelial Cells from Small Molecules and OCT4 Reprogrammed Human Induced Pluripotent Stem Cells.
T. U. Krohne, P. D. Westenskow, T. Kurihara, D. F. Friedlander, M. Lehmann, A. L. Dorsey, W. Li, S. Zhu, A. Schultz, J. Wang, et al. (2012)
Stem Cells Trans Med
1, 96-109
|Abstract »|Full Text »|PDF »
Controlling the Stem Cell Compartment and Regeneration In Vivo: The Role of Pluripotency Pathways.
Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts.
N. Ali, H. Allam, R. May, S. M. Sureban, M. S. Bronze, T. Bader, S. Umar, S. Anant, and C. W. Houchen (2011)
J. Virol.
85, 12292-12303
|Abstract »|Full Text »|PDF »
Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells.
E. Varela, R. P. Schneider, S. Ortega, and M. A. Blasco (2011)
PNAS
108, 15207-15212
|Abstract »|Full Text »|PDF »
The evolving biology of cell reprogramming.
I. Wilmut, G. Sullivan, and I. Chambers (2011)
Phil Trans R Soc B
366, 2183-2197
|Abstract »|Full Text »|PDF »
Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling.
Establishment of induced pluripotent stem cells from aged mice using bone marrow-derived myeloid cells.
Z. Cheng, S. Ito, N. Nishio, H. Xiao, R. Zhang, H. Suzuki, Y. Okawa, T. Murohara, and K.-i. Isobe (2011)
J Mol Cell Biol
3, 91-98
|Abstract »|Full Text »|PDF »
Amniocytes can serve a dual function as a source of iPS cells and feeder layers.
R. M. Anchan, P. Quaas, B. Gerami-Naini, H. Bartake, A. Griffin, Y. Zhou, D. Day, J. L. Eaton, L. L. George, C. Naber, et al. (2011)
Hum. Mol. Genet.
20, 962-974
|Abstract »|Full Text »|PDF »
T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell.
T. Serwold, K. Hochedlinger, J. Swindle, J. Hedgpeth, R. Jaenisch, and I. L. Weissman (2010)
PNAS
107, 18939-18943
|Abstract »|Full Text »|PDF »
Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
M. Masip, A. Veiga, J. C. Izpisua Belmonte, and C. Simon (2010)
Mol. Hum. Reprod.
16, 856-868
|Abstract »|Full Text »|PDF »
Generation of Induced Pluripotent Stem Cells in Rabbits: POTENTIAL EXPERIMENTAL MODELS FOR HUMAN REGENERATIVE MEDICINE.
A. Honda, M. Hirose, M. Hatori, S. Matoba, H. Miyoshi, K. Inoue, and A. Ogura (2010)
J. Biol. Chem.
285, 31362-31369
|Abstract »|Full Text »|PDF »
Induction of Pluripotent Stem Cells from Human Third Molar Mesenchymal Stromal Cells.
Y. Oda, Y. Yoshimura, H. Ohnishi, M. Tadokoro, Y. Katsube, M. Sasao, Y. Kubo, K. Hattori, S. Saito, K. Horimoto, et al. (2010)
J. Biol. Chem.
285, 29270-29278
|Abstract »|Full Text »|PDF »
Promotion of direct reprogramming by transformation-deficient Myc.
M. Nakagawa, N. Takizawa, M. Narita, T. Ichisaka, and S. Yamanaka (2010)
PNAS
107, 14152-14157
|Abstract »|Full Text »|PDF »
Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells.
N. J. Leeper, A. L. Hunter, and J. P. Cooke (2010)
Circulation
122, 517-526
|Full Text »|PDF »
Minireview: {beta}-Cell Replacement Therapy for Diabetes in the 21st Century: Manipulation of Cell Fate by Directed Differentiation.
Robust activation of the human but not mouse telomerase gene during the induction of pluripotency.
R. Mathew, W. Jia, A. Sharma, Y. Zhao, L. E. Clarke, X. Cheng, H. Wang, U. Salli, K. E. Vrana, G. P. Robertson, et al. (2010)
FASEB J
24, 2702-2715
|Abstract »|Full Text »|PDF »
Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation.
H.-J. Cho, C.-S. Lee, Y.-W. Kwon, J. S. Paek, S.-H. Lee, J. Hur, E. J. Lee, T.-Y. Roh, I.-S. Chu, S.-H. Leem, et al. (2010)
Blood
116, 386-395
|Abstract »|Full Text »|PDF »
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell-Based Regeneration.
Y. Yoshida and S. Yamanaka (2010)
Circulation
122, 80-87
|Full Text »|PDF »
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.
Y. Mizuno, H. Chang, K. Umeda, A. Niwa, T. Iwasa, T. Awaya, S.-i. Fukada, H. Yamamoto, S. Yamanaka, T. Nakahata, et al. (2010)
FASEB J
24, 2245-2253
|Abstract »|Full Text »|PDF »
Roadblocks en route to the clinical application of induced pluripotent stem cells.
Functional Recapitulation of Smooth Muscle Cells Via Induced Pluripotent Stem Cells From Human Aortic Smooth Muscle Cells.
T.-H. Lee, S.-H. Song, K. L. Kim, J.-Y. Yi, G.-H. Shin, J. Y. Kim, J. Kim, Y.-M. Han, S. H. Lee, S.-H. Lee, et al. (2010)
Circ. Res.
106, 120-128
|Abstract »|Full Text »|PDF »
Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro.
A. Kuzmenkin, H. Liang, G. Xu, K. Pfannkuche, H. Eichhorn, A. Fatima, H. Luo, T. Saric, M. Wernig, R. Jaenisch, et al. (2009)
FASEB J
23, 4168-4180
|Abstract »|Full Text »|PDF »
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
C. Li, J. Zhou, G. Shi, Y. Ma, Y. Yang, J. Gu, H. Yu, S. Jin, Z. Wei, F. Chen, et al. (2009)
Hum. Mol. Genet.
18, 4340-4349
|Abstract »|Full Text »|PDF »
Genomic and Expression Profiling of Glioblastoma Stem Cell-Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival.
A. Ernst, S. Hofmann, R. Ahmadi, N. Becker, A. Korshunov, F. Engel, C. Hartmann, J. Felsberg, M. Sabel, H. Peterziel, et al. (2009)
Clin. Cancer Res.
15, 6541-6550
|Abstract »|Full Text »|PDF »
Forward programming of pluripotent stem cells towards distinct cardiovascular cell types.
R. David, J. Stieber, E. Fischer, S. Brunner, C. Brenner, S. Pfeiler, F. Schwarz, and W.-M. Franz (2009)
Cardiovasc Res
84, 263-272
|Abstract »|Full Text »|PDF »
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.
Current Advances and Travails in Islet Transplantation.
D. M. Harlan, N. S. Kenyon, O. Korsgren, B. O. Roep, and for the Immunology of Diabetes Society (2009)
Diabetes
58, 2175-2184
|Full Text »|PDF »
Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.
J. Utikal, N. Maherali, W. Kulalert, and K. Hochedlinger (2009)
J. Cell Sci.
122, 3502-3510
|Abstract »|Full Text »|PDF »
Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.
M. Okabe, M. Otsu, D. H. Ahn, T. Kobayashi, Y. Morita, Y. Wakiyama, M. Onodera, K. Eto, H. Ema, and H. Nakauchi (2009)
Blood
114, 1764-1767
|Abstract »|Full Text »|PDF »
Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells.
T. J. Nelson, A. Martinez-Fernandez, S. Yamada, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circulation
120, 408-416
|Abstract »|Full Text »|PDF »
Derivation of induced pluripotent stem cells from pig somatic cells.
T. Ezashi, B. P. V. L. Telugu, A. P. Alexenko, S. Sachdev, S. Sinha, and R. M. Roberts (2009)
PNAS
106, 10993-10998
|Abstract »|Full Text »|PDF »
Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig.
M. A. Esteban, J. Xu, J. Yang, M. Peng, D. Qin, W. Li, Z. Jiang, J. Chen, K. Deng, M. Zhong, et al. (2009)
J. Biol. Chem.
284, 17634-17640
|Abstract »|Full Text »|PDF »
Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.
L. Ye, J. C. Chang, C. Lin, X. Sun, J. Yu, and Y. W. Kan (2009)
PNAS
106, 9826-9830
|Abstract »|Full Text »|PDF »
Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector.
F. Gonzalez, M. Barragan Monasterio, G. Tiscornia, N. Montserrat Pulido, R. Vassena, L. Batlle Morera, I. Rodriguez Piza, and J. C. I. Belmonte (2009)
PNAS
106, 8918-8922
|Abstract »|Full Text »|PDF »
Phenobarbital Elicits Unique, Early Changes in the Expression of Hepatic Genes that Affect Critical Pathways in Tumor-Prone B6C3F1 Mice.
J. M. Phillips, L. D. Burgoon, and J. I. Goodman (2009)
Toxicol. Sci.
109, 193-205
|Abstract »|Full Text »|PDF »
Reprogramming to a muscle fate by fusion recapitulates differentiation.
J. H. Pomerantz, S. Mukherjee, A. T. Palermo, and H. M. Blau (2009)
J. Cell Sci.
122, 1045-1053
|Abstract »|Full Text »|PDF »
Multiple Genes Exhibit Phenobarbital-Induced Constitutive Active/Androstane Receptor-Mediated DNA Methylation Changes during Liver Tumorigenesis and in Liver Tumors.
Klf4 reverts developmentally programmed restriction of ground state pluripotency.
G. Guo, J. Yang, J. Nichols, J. S. Hall, I. Eyres, W. Mansfield, and A. Smith (2009)
Development
136, 1063-1069
|Abstract »|Full Text »|PDF »
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells.
J. Zhang, G. F. Wilson, A. G. Soerens, C. H. Koonce, J. Yu, S. P. Palecek, J. A. Thomson, and T. J. Kamp (2009)
Circ. Res.
104, e30-e41
|Abstract »|Full Text »|PDF »
Epigenetic reprogramming and induced pluripotency.
Mouse Meningiocytes Express Sox2 and Yield High Efficiency of Chimeras after Nuclear Reprogramming with Exogenous Factors.
D. Qin, Y. Gan, K. Shao, H. Wang, W. Li, T. Wang, W. He, J. Xu, Y. Zhang, Z. Kou, et al. (2008)
J. Biol. Chem.
283, 33730-33735
|Abstract »|Full Text »|PDF »
Induced Pluripotent Stem Cells Generated Without Viral Integration.
M. Stadtfeld, M. Nagaya, J. Utikal, G. Weir, and K. Hochedlinger (2008)
Science
322, 945-949
|Abstract »|Full Text »|PDF »
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors.
K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka (2008)
Science
322, 949-953
|Abstract »|Full Text »|PDF »
Induced Pluripotency of Mouse and Human Somatic Cells.
N. Maherali and K. Hochedlinger (2008)
Cold Spring Harb Symp Quant Biol
|Abstract »|PDF »
Reprogramming of Somatic Cell Identity.
J. Hanna, B.W. Carey, and R. Jaenisch (2008)
Cold Spring Harb Symp Quant Biol
|Abstract »|PDF »
Mapping Key Features of Transcriptional Regulatory Circuitry in Embryonic Stem Cells.
M.F. Cole and R.A. Young (2008)
Cold Spring Harb Symp Quant Biol
|Abstract »|PDF »